(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …
Read More »
CHICAGO / NEW YORK (Reuters) – Approximately one-fifth of the 11,000 people enrolled in a 30,000-volunteer U.S. trial of a Pfizer COVID-19 vaccine (PFE.N) and German partner BioNTech (22UAy.F) are Black as Latino, groups among the hardest hit by the coronavirus virus pandemic, said a top Pfizer executive. PHILO PHOTO: …
Read More »
LONDON (Reuters) – Russia’s plan to roll out its “Sputnik-V” COVID-19 vaccine, even before full studies show how well it works, requires concern among virus experts, who warn of a partially effective shot at the new encourage coronavirus to mutate. PHILO PHOTO: A handout photo provided by the Russian Direct …
Read More »
(Reuters) – A US government program that compensates people who say they are harmed by an emergency vaccine has paid out on less than 10% of claims, raising questions about whether the process should be used to deal with any side effects from a coronavirus shot to sue, according to …
Read More »
FILE PHOTO: Office workers wearing protective face masks run in Singapore’s central business district during coronavirus outbreak (COVID-19), 17 August 2020. REUTERS / Edgar Su SINGAPORE (Reuters) – Researchers in Singapore have discovered a new variant of the COVID-19 coronavirus that causes milder infections, according to a study published in …
Read More »